Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD184 Rat anti-Mouse, APC-R700, Clone: 2B11/CXCR4, BD

Rat Monoclonal Antibody

Supplier:  BD Biosciences 565522

Catalog No. BDB565522


Description

Description

The 2B11/CXCR4 monoclonal antibody specifically binds to mouse CD184, which is also known as the C-X-C Chemokine Receptor type 4 , CXCR4. CXCR4 (previously known as Fusin and LESTR), is a seven-transmembrane, G-protein-coupled receptor. It is the specific receptor for the CXC chemokine, SDF-1/CXCL12. Mouse CXCR4 shows 91% homology at the amino acid level with human CXCR4. CXCR4 is widely expressed by hematopoietic and non-hematopoietic cell types including neutrophils, monocytes, T cells, B cells, CD34-positive progenitor cells, endothelial cells, neurons and astrocytes. Human CXCR4 is used by T-tropic HIV-1 as a co-receptor for viral entry. The mouse Cxcr4 gene has been mapped to chromosome 1.

TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD184
Monoclonal
0.2mg/mL
CXCR4, C-X-C chemokine receptor type 4; Fusin; LESTR; PB-CKR; Sdf1r
Rat
Affinity Purified
RUO
12767
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Flow Cytometry
2B11/CXCR4
APC-R700
Aqueous buffered solution containing protein stabilizer and ≤0.09% sodium azide.
GST-NCXCR4 fusion protein
50 μg
Primary
Mouse
IgG2b κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.